Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.

Roger SD, Wong CM, Vejakama P, Rahardjo KD, Hsu BG, Lee CM, Wu IW, Lee CC, Situmorang TD, Krisanapan P, Mazlan SA, Peng YS, Sarwono J, De Asis N, Solimen D, Jonny, Sangthawan P, Chen JB, Wang CL, Chung S, Villaflor AJ, Yang CW, Kan WC, Yang Y, Rubio-Bicol J, Yan LY, Lee SH, Chiu YW, Chen CH, Na KY, Hassah WHHW, Kang YS, Choi BS, Aquitania G, Na KR, Wu MS, Ahmad MK, Isidto R, Wu V, Leong GB, Sung JM, Noppakun K, Chou KJ, Abdul Wahab MZ, Shin SJ, Nugroho P

Open source

DOI: 10.1111/nep.70046
Published: 2025 May
Container: Nephrology (Carlton, Vic.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/nep.70046,
  title = {Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.},
  author = {Roger SD and Wong CM and Vejakama P and Rahardjo KD and Hsu BG and Lee CM and Wu IW and Lee CC and Situmorang TD and Krisanapan P and Mazlan SA and Peng YS and Sarwono J and De Asis N and Solimen D and Jonny and Sangthawan P and Chen JB and Wang CL and Chung S and Villaflor AJ and Yang CW and Kan WC and Yang Y and Rubio-Bicol J and Yan LY and Lee SH and Chiu YW and Chen CH and Na KY and Hassah WHHW and Kang YS and Choi BS and Aquitania G and Na KR and Wu MS and Ahmad MK and Isidto R and Wu V and Leong GB and Sung JM and Noppakun K and Chou KJ and Abdul Wahab MZ and Shin SJ and Nugroho P},
  year = {2025},
  journal = {Nephrology (Carlton, Vic.)},
  doi = {10.1111/nep.70046},
  url = {https://doi.org/10.1111/nep.70046}
}

RIS

TY  - JOUR
TI  - Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.
AU  - Roger SD
AU  - Wong CM
AU  - Vejakama P
AU  - Rahardjo KD
AU  - Hsu BG
AU  - Lee CM
AU  - Wu IW
AU  - Lee CC
AU  - Situmorang TD
AU  - Krisanapan P
AU  - Mazlan SA
AU  - Peng YS
AU  - Sarwono J
AU  - De Asis N
AU  - Solimen D
AU  - Jonny
AU  - Sangthawan P
AU  - Chen JB
AU  - Wang CL
AU  - Chung S
AU  - Villaflor AJ
AU  - Yang CW
AU  - Kan WC
AU  - Yang Y
AU  - Rubio-Bicol J
AU  - Yan LY
AU  - Lee SH
AU  - Chiu YW
AU  - Chen CH
AU  - Na KY
AU  - Hassah WHHW
AU  - Kang YS
AU  - Choi BS
AU  - Aquitania G
AU  - Na KR
AU  - Wu MS
AU  - Ahmad MK
AU  - Isidto R
AU  - Wu V
AU  - Leong GB
AU  - Sung JM
AU  - Noppakun K
AU  - Chou KJ
AU  - Abdul Wahab MZ
AU  - Shin SJ
AU  - Nugroho P
PY  - 2025
JO  - Nephrology (Carlton, Vic.)
DO  - 10.1111/nep.70046
UR  - https://doi.org/10.1111/nep.70046
ER  -

APA

SD, R., CM, W., P, V., KD, R., BG, H., CM, L., IW, W., CC, L., TD, S., P, K., SA, M., YS, P., J, S., N, D. A., D, S., Jonny, P, S., JB, C., CL, W., S, C., AJ, V., CW, Y., WC, K., Y, Y., J, R., LY, Y., SH, L., YW, C., CH, C., KY, N., WHHW, H., YS, K., BS, C., G, A., KR, N., MS, W., MK, A., R, I., V, W., GB, L., JM, S., K, N., KJ, C., MZ, A. W., SJ, S., & P, N. (2025). Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.. Nephrology (Carlton, Vic.). https://doi.org/10.1111/nep.70046

Source records

pubmed · retrieved 2026-09-26T10:49:17.948Z